109 related articles for article (PubMed ID: 18315457)
21. Long-term stimulant medication treatment of attention-deficit/hyperactivity disorder: results from a population-based study.
Barbaresi WJ; Katusic SK; Colligan RC; Weaver AL; Leibson CL; Jacobsen SJ
J Dev Behav Pediatr; 2014 Sep; 35(7):448-57. PubMed ID: 25180895
[TBL] [Abstract][Full Text] [Related]
22. Newly approved once-daily formulations of medications for the treatment of Attention Deficit (Hyperactivity) Disorder (ADHD) in children and adolescents.
Roman MW
Issues Ment Health Nurs; 2010 Aug; 31(8):548-9. PubMed ID: 20624025
[No Abstract] [Full Text] [Related]
23. Stimulant dosing in the community treatment of adult attention-deficit/hyperactivity disorder.
Olfson M; Marcus SC; Zhang HF; Wan GJ
J Clin Psychopharmacol; 2008 Apr; 28(2):255-7. PubMed ID: 18344749
[No Abstract] [Full Text] [Related]
24. [Risperidone-induced tardive dystonia: a case of torticollis].
Fdhil H; Krebs MO; Bayle F; Vanelle JM; Olie JP
Encephale; 1998; 24(6):581-3. PubMed ID: 9949942
[TBL] [Abstract][Full Text] [Related]
25. Risperidone and tardive dyskinesia.
Feeney DJ; Klykylo W
J Am Acad Child Adolesc Psychiatry; 1996 Nov; 35(11):1421-2. PubMed ID: 8936904
[No Abstract] [Full Text] [Related]
26. Duration of effect of oral long-acting stimulant medications for ADHD throughout the day.
Brams M; Moon E; Pucci M; López FA
Curr Med Res Opin; 2010 Aug; 26(8):1809-25. PubMed ID: 20491612
[TBL] [Abstract][Full Text] [Related]
27. Not just another antipsychotic-for-conduct-problems trial.
Blader JC
J Am Acad Child Adolesc Psychiatry; 2014 Jan; 53(1):17-20. PubMed ID: 24342382
[No Abstract] [Full Text] [Related]
28. Risperidone-induced sexual dysfunction in a prepubertal child - a case report.
Wadoo O; Chalhoub N
J Psychopharmacol; 2009 Aug; 23(6):727-8. PubMed ID: 18562402
[TBL] [Abstract][Full Text] [Related]
29. Predictors of weight loss in children with attention deficit hyperactivity disorder treated with stimulant medication.
Schertz M; Adesman AR; Alfieri NE; Bienkowski RS
Pediatrics; 1996 Oct; 98(4 Pt 1):763-9. PubMed ID: 8885958
[TBL] [Abstract][Full Text] [Related]
30. Acute dystonia induced by adding midodrine, a selective alpha 1 agonist, to risperidone in a patient with catatonic schizophrenia.
Takahashi H
J Neuropsychiatry Clin Neurosci; 2000; 12(2):285-6. PubMed ID: 11001613
[No Abstract] [Full Text] [Related]
31. Elderly nursing home resident with head drop.
Abel Boenerjous RS; Zirker W; Masilamani S
J Am Med Dir Assoc; 2015 May; 16(5):433-4. PubMed ID: 25748817
[No Abstract] [Full Text] [Related]
32. [Hyperprolactinemia in a child diagnosed with Asperger syndrome and hyperkinetic disorder treated with risperidone].
Monge Galindo L; Escosa García L; García Sánchez N; Ruiz-Lázaro PM
An Pediatr (Barc); 2009 Jul; 71(1):86-7. PubMed ID: 19473900
[No Abstract] [Full Text] [Related]
33. Extrapyramidal Symptoms as a Result of Risperidone Discontinuation During Combination Therapy with Methylphenidate in a Pediatric Patient.
Pérez CA; Garcia SS; Yu RD
J Child Adolesc Psychopharmacol; 2016 Mar; 26(2):182. PubMed ID: 26871198
[No Abstract] [Full Text] [Related]
34. Acute Laryngeal Dystonia With Novel Antipsychotics: A Case Report and Review of Literature.
Ganesh M; Jabbar U; Iskander FH
J Clin Psychopharmacol; 2015 Oct; 35(5):613-5. PubMed ID: 26252439
[No Abstract] [Full Text] [Related]
35. From the Editor-in-Chief's Desk.
Koplewicz HS
J Child Adolesc Psychopharmacol; 2015 Aug; 25(6):457. PubMed ID: 26262901
[No Abstract] [Full Text] [Related]
36. Acute dystonia induced by rapid increase in risperidone dosage.
Brody AL
J Clin Psychopharmacol; 1996 Dec; 16(6):461-2. PubMed ID: 8959475
[No Abstract] [Full Text] [Related]
37. Circadian pattern of acute, neuroleptic-induced dystonic reactions.
Mazurek MF; Rosebush PI
Am J Psychiatry; 1996 May; 153(5):708-10. PubMed ID: 8615420
[TBL] [Abstract][Full Text] [Related]
38. Dystonia while changing from clozapine to risperidone.
Simpson GM; Meyer JM
J Clin Psychopharmacol; 1996 Jun; 16(3):260-1. PubMed ID: 8784665
[No Abstract] [Full Text] [Related]
39. Bulimia nervosa and attention deficit hyperactivity disorder: a possible role for stimulant medication.
Dukarm CP
J Womens Health (Larchmt); 2005 May; 14(4):345-50. PubMed ID: 15916509
[TBL] [Abstract][Full Text] [Related]
40. Antecollis, lingual dystonia, and mutism secondary to risperidone.
Sharma V; Biswas DD
J Neuropsychiatry Clin Neurosci; 2012; 24(3):E42-3. PubMed ID: 23037680
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
